February 5, 2008
SpeculatingStocks.com Stock Pick: Aastrom Biosciences, Inc. (ASTM)
Stock Price: $0.75
Aastrom Biosciences, Inc. develops autologous cell products for the repair or regeneration of human tissue. The company's proprietary Tissue Repair Cell (TRC) technology involves the use of a patient's own cells to manufacture products to treat a range of chronic diseases and serious injuries affecting vascular, bone, cardiac and neural tissues.
Earlier this year, on January 15th, ASTM announced that the first patient has been treated with the company's autologous stem cell therapy for dilated cardiomyopathy (DCM). This was the first human application of ASTM's Cardiac Repair Cell (CRC) product to regenerate damaged heart tissue in patients with severely impaired cardiac function.
This is a huge milestone for the company and stem cell research and implementation as a whole.
ASTM is trading at a market cap of only around $100.25 million. The company has $24.30 million in cash and cash equivalents on the balance sheet and long-term debt of around $1.0 million. ASTM's assets exceed liabilities by over 6.50 to 1.
ASTM has had momentum the last few trading days and has a nice chart. ASTM is NASDAQ listed and needs to trade back above $1.00 in excess of ten consecutive business days before June 17, 2008. We believe this is achievable for ASTM.